Skip to main content

Table 3 Notes on liver injury

From: Liver injury in COVID-19: clinical features and treatment management

Author

Patient

Abnormal liver biochemical indexes

Liver injury note

Time trend of liver enzyme elevation

Huang [10]

41

ALT: 32.0 (21.0–50.0) U/L

AST: 34.0 (26.0–48.0) U/L

TBIL: 11.7 (9.5–13.9) μmol/L

There were significant differences in liver biochemical indexes between severe patients and mild patients (all P < 0.05)

Not mentioned

Chen [9]

99

ALT: 39.0 (22.0–53.0) U/L

AST: 34.0 (26.0–48.0) U/L

TBIL: 15.1 (7.3) μmol/L

Most patients had mild liver dysfunction

Liver enzymes increased slightly

Zhang [6]

115

ALT: 25.71 (9–50) U/L

AST: 28.30 (15–40) U/L

TBIL: 11.31 (5–21) μmol/L

Slight abnormality of liver function; There were significant differences in liver biochemical indexes between severe patients and mild patients (all P < 0.05)

The changes of ALT, AST and TBIL in ICU patients were not significant with time (P > 0.05)

Bloom [5]

60

ALT: 39 (15.0–63.0) U/L

AST: 55 (18–92) U/L

TBIL: 0.9 ± 2.2 μmol/L

It has been proved that patients with severe COVID-19 have higher biochemical levels of liver

ALT and AST showed the same trend

With the extension of time, there was a slight increase, which reached the peak on the ninth day, and then decreased slowly, and the increase was not more than 40 U/L

Wang [30]

138

ALT: 24 (16–40) U/L

AST: 31 (24–51) U/L

TBIL: 9.8 (8.4–14.1) μmol/L

The levels of ALT and AST in ICU patients were significantly higher than those not in ICU patients

Not mentioned

Cardoso [31]

20 (critically ill patients)

Not mentioned

Liver injury is common, but usually transient and not severe. However, cholestasis is obvious

ALT and AST only increased slightly(10d in ICU), and the highest < 2 × ULN

GGT increased more and more obviously, reaching 3 × ULN

Cai [3]

417

ALT: 21 (15–31) U/L

AST: 26.5 (21–35) U/L

TBIL: 10.9 (8.3–16.3) μmol/L

AST, ALT and GGT were higher in severe patients

The increase of ALT and GGT was common, but the frequency of AST and TBIL was slightly lower

Xu [8]

25 (death)

ALT: 24 (16.5–46) U/L

AST: 37 (29.5–57.5) U/L

Slight abnormality of liver function

Not mentioned

Wang [32]

105

ALT: 23.5 (14.0–36.0) U/L (N = 105)

AST: 24.2 (19.7, 34.8) U/L (N = 50)

TBIL: 10.2 (7.4, 12.9) μmol/L (N = 50)

Severe COVID-19 patients are more likely to have liver dysfunction

During the treatment, most of the patients only had mild or isolated elevation, and most of them were normal after discharge